PTX 2.44% 4.2¢ prescient therapeutics limited

Ann: PTX-100 progresses to next cohort in basket clinical study, page-4

  1. 113 Posts.
    lightbulb Created with Sketch. 4
    "One patient in 500mg/m2 cohort has multi-chemorefractory PTCL and is stable while and the other patient, who has cutaneous T cell lymphoma (CTCL) and achieved a partial response (PR). Both of these patients have received 9 cycles of PTX-100 treatment."

    great news!
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.2¢
Change
0.001(2.44%)
Mkt cap ! $33.82M
Open High Low Value Volume
4.1¢ 4.3¢ 4.1¢ $27.29K 650.9K

Buyers (Bids)

No. Vol. Price($)
2 74314 4.1¢
 

Sellers (Offers)

Price($) Vol. No.
4.3¢ 57451 1
View Market Depth
Last trade - 16.10pm 02/08/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.